Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus-Reference-Cited by-同舟云学术

Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus

Published:2016-06-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pai Madhukar¹,Reingold Arthur L²,Riley Lee W³,Colford John M⁴,Ojubolamo Olakunle⁵,Mthiyane Thuli⁶

Affiliation:

1. McGill University; Department of Epidemiology, Biostatistics and Occupational Health; Purvis Hall, Room 50 1020 Pine Avenue West Montreal QC Canada H3A 1A2

2. University of California at Berkeley; Division of Epidemiology; 140 Warren Hall Berkeley CA USA 94720

3. University of California at Berkeley; Division of Infectious Diseases; 140 Warren Hall School of Public Health Berkeley CA USA CA 94720

4. University of California at Berkeley; Epidemiology; 140 Warren Hall School of Public Health Berkeley CA USA CA 94720

5. Glasgow UK

6. Medical Research Council; Durban South Africa

Publisher

Wiley

Subject

Pharmacology (medical)

Reference30 articles.

1. Treatment of tuberculosis and tuberculosis infection in adults and children;Am J Respir Crit Care Med,1994

2. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998;Thorax,1998

3. Bureau of Tuberculosis Control New York City Department of Health Clinical policies and protocols. New York: New York City Department of Health 1997

4. Impact of HIV on tuberculosis in sub-Saharan Africa: a regional perspective;Cantwell;Int J Tuberc Lung Dis,1997

5. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations;MMWR,1998